查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1556565

祛痰藥市場報告：2030 年趨勢、預測與競爭分析

Expectorant Drug Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

祛痰趨勢與預測

預計到 2030 年，全球祛痰藥市場預計將達到 211 億美元，2024 年至 2030 年的複合年成長率為 4.2%。這個市場的主要驅動力是導致喉嚨乾燥的干咳發病率上升、氣喘和慢性阻塞性肺病（COPD）等呼吸系統疾病發病率上升，以及藥物配方和給藥方式的變化。 。全球祛痰藥市場前景廣闊，醫院藥局、零售、藥局和網路藥局市場充滿機會。

按部位分類的祛痰藥

本研究按藥物類型、劑型、產品類型、分銷管道和地區對全球祛痰藥市場進行了預測。

祛痰藥市場洞察

Lucintel 預測，在預測期內，促分泌劑仍將佔據較大佔有率，因為它們有益於治療多種呼吸系統疾病。

零售店將繼續成為該市場最大的部分。

由於研發活動的增加以及政府政策和核准的不斷變化，北美在預測期內將繼續成為最大的地區。

常問問題

Q1.市場規模為：

A1. 到 2030 年，全球祛痰藥市場預計將達到 211 億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，全球祛痰藥市場預計複合年成長率為4.2%。

Q3.影響市場成長的主要促進因素是：

A3.該市場的主要驅動力是導致喉嚨乾燥的干咳發病率增加、氣喘和慢性阻塞性肺病（COPD）等呼吸系統疾病的發病率增加，以及通過改善祛痰劑的性能。 。

Q4.市場的主要細分市場是：

A4. 全球祛痰藥市場前景廣闊，醫院藥局、零售、藥局和網路藥局市場充滿機會。

Q5.市場的主要企業是：

A5. 主要祛痰藥公司如下：

  • Abbott Laboratories
  • Acella Pharmaceuticals
  • AstraZeneca
  • Cipla Limited
  • Dabur
  • Glenmark Pharmaceuticals
  • Johnson and Johnson
  • Merck
  • Novartis International
  • Pfizer

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計促泌劑在預測期內仍將佔據更大的市場佔有率，因為它們有益於治療多種呼吸系統疾病。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 由於研發活動的增加以及政府政策和核准的進展，預計北美在預測期內仍將是最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球祛痰藥市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球祛痰藥市場趨勢（2018-2023）與預測（2024-2030）
  • 按藥物類型分類的全球祛痰藥市場
    • 分泌促效劑
    • 黏液溶解藥物
  • 按劑型分類的全球祛痰藥市場
    • 口服固態劑型
    • 口服液
    • 吸入劑
  • 按產品類型分類的全球祛痰藥市場
    • 商店藥 (OTC)
    • 處方藥
  • 按分銷管道分類的全球祛痰藥市場
    • 醫院藥房
    • 零售店
    • 藥局
    • 網路藥房
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球祛痰藥市場（按地區）
  • 北美祛痰藥市場
  • 歐洲祛痰藥市場
  • 亞太祛痰藥市場
  • 其他地區祛痰藥市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按藥物類型分類的全球祛痰藥市場成長機會
    • 按劑型分類的全球祛痰藥市場成長機會
    • 按產品類型分類的全球祛痰劑市場成長機會
    • 按分銷管道分類的全球祛痰藥市場成長機會
    • 按地區分類的全球祛痰藥市場成長機會
  • 全球祛痰藥市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球祛痰藥市場產能
    • 全球祛痰藥市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • Abbott Laboratories
  • Acella Pharmaceuticals
  • AstraZeneca
  • Cipla Limited
  • Dabur
  • Glenmark Pharmaceuticals
  • Johnson and Johnson
  • Merck
  • Novartis International
  • Pfizer
簡介目錄

Expectorant Drug Trends and Forecast

The future of the global expectorant drug market looks promising with opportunities in the hospital pharmacy, retail store, drug store, and online pharmacy markets. The global expectorant drug market is expected to reach an estimated $21.1 billion by 2030 with a CAGR of 4.2% from 2024 to 2030. The major drivers for this market are growing number of incidences of dry cough that lead to dry throats, rising rates of respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), as well as, improvements in the performance of expectorant drugs owing to developments and advances in drug formulation and delivery methods.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Expectorant Drug by Segment

The study includes a forecast for the global expectorant drug by drug type, dosage form, product type, distribution channel, and region.

Expectorant Drug Market by Drug Type [Shipment Analysis by Value from 2018 to 2030]:

  • Secretion Enhancer
  • Mucolytics

Expectorant Drug Market by Dosage Form [Shipment Analysis by Value from 2018 to 2030]:

  • Oral Solid
  • Oral Liquid
  • Inhalant

Expectorant Drug Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Over-The-Counter
  • Prescription Drug

Expectorant Drug Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Retail Store
  • Drug Store
  • Online Pharmacies
  • Others

Expectorant Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Expectorant Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies expectorant drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the expectorant drug companies profiled in this report include-

  • Abbott Laboratories
  • Acella Pharmaceuticals
  • AstraZeneca
  • Cipla Limited
  • Dabur
  • Glenmark Pharmaceuticals
  • Johnson and Johnson
  • Merck
  • Novartis International
  • Pfizer

Expectorant Drug Market Insights

Lucintel forecasts that secretion enhancer will remain larger segment over the forecast period due to they are beneficial in the management of several respiratory conditions.

Within this market, retail store will remain the largest segment.

North America will remain the largest region over the forecast period due to growing number of research and development activities, along with government policies and approvals in the region.

Features of the Global Expectorant Drug Market

Market Size Estimates: Expectorant drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Expectorant drug market size by drug type, dosage form, product type, distribution channel, and region in terms of value ($B).

Regional Analysis: Expectorant drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different drug type, dosage form, product type, distribution channel, and regions for the expectorant drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the expectorant drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the expectorant drug market size?

Answer: The global expectorant drug market is expected to reach an estimated $21.1 billion by 2030.

Q2. What is the growth forecast for expectorant drug market?

Answer: The global expectorant drug market is expected to grow with a CAGR of 4.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the expectorant drug market?

Answer: The major drivers for this market are growing number of incidences of dry cough that lead to dry throats, rising rates of respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), as well as, improvements in the performance of expectorant drugs owing to developments and advances in drug formulation and delivery methods.

Q4. What are the major segments for expectorant drug market?

Answer: The future of the global expectorant drug market looks promising with opportunities in the hospital pharmacy, retail store, drug store, and online pharmacy markets.

Q5. Who are the key expectorant drug market companies?

Answer: Some of the key expectorant drug companies are as follows:

  • Abbott Laboratories
  • Acella Pharmaceuticals
  • AstraZeneca
  • Cipla Limited
  • Dabur
  • Glenmark Pharmaceuticals
  • Johnson and Johnson
  • Merck
  • Novartis International
  • Pfizer

Q6. Which expectorant drug market segment will be the largest in future?

Answer: Lucintel forecasts that secretion enhancer will remain larger segment over the forecast period due to they are beneficial in the management of several respiratory conditions.

Q7. In expectorant drug market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing number of research and development activities, along with government policies and approvals in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the expectorant drug market by drug type (secretion enhancer and mucolytics), dosage form (oral solid, oral liquid, and inhalant), product type (over-the-counter and prescription drug), distribution channel (hospital pharmacies, retail store, drug store, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Expectorant Drug Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Expectorant Drug Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Expectorant Drug Market by Drug Type
    • 3.3.1: Secretion Enhancer
    • 3.3.2: Mucolytics
  • 3.4: Global Expectorant Drug Market by Dosage Form
    • 3.4.1: Oral Solid
    • 3.4.2: Oral Liquid
    • 3.4.3: Inhalant
  • 3.5: Global Expectorant Drug Market by Product Type
    • 3.5.1: Over-The-Counter
    • 3.5.2: Prescription Drug
  • 3.6: Global Expectorant Drug Market by Distribution Channel
    • 3.6.1: Hospital Pharmacies
    • 3.6.2: Retail Store
    • 3.6.3: Drug Store
    • 3.6.4: Online Pharmacies
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Expectorant Drug Market by Region
  • 4.2: North American Expectorant Drug Market
    • 4.2.1: North American Expectorant Drug Market by Drug Type: Secretion Enhancer and Mucolytics
    • 4.2.2: North American Expectorant Drug Market by Distribution Channel: Hospital Pharmacies, Retail Store, Drug Store, Online Pharmacies, and Others
  • 4.3: European Expectorant Drug Market
    • 4.3.1: European Expectorant Drug Market by Drug Type: Secretion Enhancer and Mucolytics
    • 4.3.2: European Expectorant Drug Market by Distribution Channel: Hospital Pharmacies, Retail Store, Drug Store, Online Pharmacies, and Others
  • 4.4: APAC Expectorant Drug Market
    • 4.4.1: APAC Expectorant Drug Market by Drug Type: Secretion Enhancer and Mucolytics
    • 4.4.2: APAC Expectorant Drug Market by Distribution Channel: Hospital Pharmacies, Retail Store, Drug Store, Online Pharmacies, and Others
  • 4.5: ROW Expectorant Drug Market
    • 4.5.1: ROW Expectorant Drug Market by Drug Type: Secretion Enhancer and Mucolytics
    • 4.5.2: ROW Expectorant Drug Market by Distribution Channel: Hospital Pharmacies, Retail Store, Drug Store, Online Pharmacies, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Expectorant Drug Market by Drug Type
    • 6.1.2: Growth Opportunities for the Global Expectorant Drug Market by Dosage Form
    • 6.1.3: Growth Opportunities for the Global Expectorant Drug Market by Product Type
    • 6.1.4: Growth Opportunities for the Global Expectorant Drug Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Expectorant Drug Market by Region
  • 6.2: Emerging Trends in the Global Expectorant Drug Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Expectorant Drug Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Expectorant Drug Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: Acella Pharmaceuticals
  • 7.3: AstraZeneca
  • 7.4: Cipla Limited
  • 7.5: Dabur
  • 7.6: Glenmark Pharmaceuticals
  • 7.7: Johnson and Johnson
  • 7.8: Merck
  • 7.9: Novartis International
  • 7.10: Pfizer